SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-024759
Filing Date
2022-11-14
Accepted
2022-11-14 08:56:38
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K gls-20221114.htm   iXBRL 8-K 63020
2 EX-99.1 gls-ex99_1.htm EX-99.1 760726
  Complete submission text file 0000950170-22-024759.txt   1011433

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20221114_pre.xml EX-101.PRE 12976
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20221114.xsd EX-101.SCH 3092
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20221114_lab.xml EX-101.LAB 17357
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gls-20221114_def.xml EX-101.DEF 13676
8 EXTRACTED XBRL INSTANCE DOCUMENT gls-20221114_htm.xml XML 6597
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 221380792
SIC: 2834 Pharmaceutical Preparations